Published in Medical Verdicts and Law Weekly, June 7th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Icagen, Inc.
Report 1: Icagen, Inc. (NASDAQ: ICGN) announced the formation of a drug discovery and development expert panel with the initial appointment of two distinguished pharmaceutical industry executives. Icagen's drug discovery and development expert panel, which will include individuals from both the pharmaceutical industry and academia, is being formed in order to provide ongoing advice and guidance on key scientific and clinical development issues related to the Company's portfolio of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.